![Chemical structure of 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one, CAS 82410-32-0](https://api.angenesci.com/structure/2896/82410-32-0.png)
No data
No data
No data
| CAS Number | 82410-32-0 |
| Catalog Number | AG008JZU(AGN-PC-0UM23G) |
| Chemical Name | 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one |
| EC Number | 627-054-3 |
| IUPAC Name | 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one |
| InChI | InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17) |
| InChI Key | IRSCQMHQWWYFCW-UHFFFAOYSA-N |
| MDL Number | MFCD23136978 |
| Molecular Formula | C9H13N5O4 |
| Molecular Weight | 255.2306 |
| NSC Number | 759656 |
| SMILES | NC=1NC(C=2N=CN(C2N1)COC(CO)CO)=O |
| UNII | P9G3CKZ4P5 |
| Synonyms | BIOLF-62,
BW-759,
Cytovene,
Ganciclovir,
Ganciclovir Sodium,
Ganciclovir, Monosodium Salt,
Gancyclovir,
RS-21592,
ganciclovir,
82410-32-0,
Gancyclovir,
Cytovene,
Vitrasert,
Hydroxyacyclovir,
Ganciclovirum,
Zirgan,
RS-21592,
Cymevene,
HHEMG,
Biolf 62,
BW-759U,
Ganciclovirum [Latin],
2'-NDG,
2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one,
BW 759U,
2'-Nor-2'-deoxyguanosine,
BIOLF-62,
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine,
BW-B 759U,
UNII-P9G3CKZ4P5,
DRG-0018,
BW 759,
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE,
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one,
CCRIS 9212,
GA2,
Cytovene-IV,
HSDB 6512,
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine,
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine,
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-,
MFCD00870588,
P9G3CKZ4P5,
MLS000028481,
CHEBI:465284,
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol,
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one,
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one,
Ganciclovir, 98%,
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-,
Cytovene IV,
NCGC00015471-02,
SMR000058324,
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one,
CAS-82410-32-0,
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one,
DSSTox_CID_21032,
DSSTox_RID_79613,
DSSTox_GSID_41032,
9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine,
Citovirax,
Cymevan,
Cymeven,
Virgan,
2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol,
2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one,
2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1,9-dihydro-6H-purin-6-one,
Vitrasert (TN),
Cytovene (TN),
CPD000058324,
SR-01000075894,
Ganciclovir [USAN:INN:BAN:JAN],
GCV & MSL,
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one,
Ganciclovir (JAN/USP/INN),
2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1H-purin-6-one,
Ganciclovir,(S),
BW-759,
BW-795,
IN1478,
MB3795,
Prestwick_1068,
ST-605,
Zirgan (TN),
GCV & 1110U81,
Ganciclovir [USAN:USP:INN:BAN:JAN],
Opera_ID_284,
Prestwick0_000839,
Prestwick1_000839,
Prestwick2_000839,
Prestwick3_000839,
Lopac-G-2536,
CHEMBL182,
EC 627-054-3,
G 2536,
AC1L1FZ2,
AC1Q52OB,
SCHEMBL3033,
Lopac0_000539,
BSPBio_000797,
MLS001077349,
BIDD:GT0783,
SPBio_002718,
BPBio1_000877,
ZINC1505,
DTXSID8041032,
methyl)-1H-purin-6(9H)-one,
SCHEMBL14491348,
BDBM85707,
CTK8A1866,
CTK8B5009,
KS-00000JPM,
IRSCQMHQWWYFCW-UHFFFAOYSA-N,
HMS1570H19,
HMS2090K08,
HMS2097H19,
HMS2235C21,
HMS3259B13,
HMS3261L19,
HMS3371H01,
HMS3604L19,
HMS3655M18,
HMS3714H19,
Pharmakon1600-01502362,
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol,
ACT03317,
BCP12705,
NSC_3454,
Tox21_110160,
Tox21_500539,
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one,
ANW-47031,
BBL029078,
NSC759656,
PDSP1_000816,
PDSP2_000803,
s1878,
SBB066292,
STK801910,
STL514515,
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one,
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone,
AKOS004119898,
AKOS026749928,
Tox21_110160_1,
AC-8069,
AN-5258,
CCG-204629,
CS-2014,
DB01004,
Ganciclovir, >=99% (HPLC), powder,
KS-1065,
LP00539,
MCULE-9512761592,
NC00647,
NE60398,
NSC-759656,
2-Amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6H-purin-6-one,
2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-6,9-dihydro-1H-purin-6-one,
SMP2_000038,
NCGC00015471-01,
NCGC00015471-03,
NCGC00015471-04,
NCGC00015471-05,
NCGC00015471-06,
NCGC00015471-08,
NCGC00093928-01,
NCGC00093928-02,
NCGC00168567-01,
NCGC00188980-01,
NCGC00261224-01,
9-(1,3-dihydroxy-2propoxymethyl)guanine,
AJ-08038,
AK-76645,
AN-14719,
HY-13637,
LS-73939,
SAM002548936,
SAM002589952,
SC-12208,
ZB000351,
9-(1,3-dihydroxy-2-propoxymethyl)guanine,
AB0012496,
AB2000347,
CAS_82410-32-0,
2-amino-9-((1,3-dihydroxypropan-2-yloxy),
9-(1,3-dihydroxy-2-propoxymethyl)-guanine,
EU-0100539,
FT-0611007,
G0315,
SW197135-3,
EN300-49857,
A11645,
C07019,
D00333,
J10127,
40034-EP2377510A1,
410G320,
A840322,
Ganciclovir, Antibiotic for Culture Media Use Only,
SR-01000721941,
I07-0010,
Q-201148,
SR-01000075894-1,
SR-01000075894-4,
SR-01000721941-3,
Z1259084907,
Ganciclovir, European Pharmacopoeia (EP) Reference Standard,
2-[(2-amino-6-hydroxy-9H-purin-9-yl)methoxy]propane-1,3-diol,
2-azanyl-9-[1,3-bis(oxidanyl)propan-2-yloxymethyl]-3H-purin-6-one,
Ganciclovir, United States Pharmacopeia (USP) Reference Standard,
2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}hydropurin-6-one,
Ganciclovir, Pharmaceutical Secondary Standard; Certified Reference Material,
2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-3,9-dihydro-6H-purin-6-one,
2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}-1,9-dihydro-6H-purin-6-one,
Ganciclovir, 1.0 mg/mL (1% 1M HCl in Methanol), certified reference material,
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody,
DHPG,
denosine,
Natclovir,
GANCICLOVIR SODIUM,
Ganciclovir hydrate,
Cymevene (TN),
D01LAP,
D05ARP,
C9H13N5O4,
Ganciclovir, Monosodium Salt,
ISIS 2922 + Ganciclovir,
CID3454,
Ganciclovir & D5-dgA immunotoxin,
Ganciclovir & C34-dgA immunotoxin,
Ganciclovir [USAN:BAN:INN:JAN],
C9-H13-N5-O4,
CS-O-11655,
B2097,
D015774,
GCV,
2-Amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one,
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one,
Ganciclovir, 99%, an antiviral compound for feline herpesvirus type-1 - 1g 1g,
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody,
|
| Complexity | 346 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 255.097g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 18 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 4 |
| Isotope Atom Count | 0 |
| Molecular Weight | 255.234g/mol |
| Monoisotopic Mass | 255.097g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 135A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -2.5 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335-H350-H360 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

